ArticleCells2022

Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone.

Thais Rodrigues Macedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.